The WHO classification of lymphomas: Cost-effective immunohistochemistry using a deductive reasoning "decision tree" approach: Part II: The decision rree approach: Diffuse patterns of proliferation in lymph nodes

Applied Immunohistochemistry and Molecular Morphology

Volumn 17, Issue 6, 2009, Pages 470-482

  Taylor, Clive R ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

CD markers; Decision trees; Deductive reasoning; Dendrograms; Double stains; Hodgkin lymphoma; Immunohistochemistry; Lymph nodes; Lymphadenopathy; Non Hodgkin lymphoma; WHO classification of lymphoma

Indexed keywords

CD20 ANTIGEN; CD23 ANTIGEN; CD3 ANTIGEN; CD38 ANTIGEN; CD5 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLIN D1; IMMUNOGLOBULIN M; INTERFERON REGULATORY FACTOR 4; KI 67 ANTIGEN; LEUKOSIALIN; LYMPHOCYTE MEMBRANE IMMUNOGLOBULIN; OCTAMER TRANSCRIPTION FACTOR 2; PROTEIN BCL 6; SYNDECAN 1; TRANSCRIPTION FACTOR PAX5;

B CELL LEUKEMIA; B CELL LYMPHOMA; B LYMPHOCYTE; BURKITT LYMPHOMA; CELL POPULATION; CELL PROLIFERATION; CELLULAR IMMUNITY; CLINICAL PRACTICE; COST EFFECTIVENESS ANALYSIS; DECISION TREE; DENDRITIC CELL SARCOMA; DIAGNOSTIC ACCURACY; FOLLICULAR DENDRITIC CELL; FOLLICULAR LYMPHOMA; HAIRY CELL LEUKEMIA; HISTIOCYTE; HISTIOCYTIC SARCOMA; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; LYMPH NODE; LYMPH NODE BIOPSY; LYMPHATIC LEUKEMIA; LYMPHOCYTOMA; LYMPHOMA; MANTLE CELL LYMPHOMA; MARGINAL ZONE LYMPHOMA; METASTASIS; NODAL MARGINAL ZONE LYMPHOMA; NODULAR LYMPHOCYTE PREDOMINANT HODGKIN LYMPHOMA; PERIPHERAL T CELL LYMPHOMA; PHENOTYPE; PHYLOGENETIC TREE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; T CELL LEUKEMIA; T LYMPHOCYTE; TUMOR CLASSIFICATION; WORLD HEALTH ORGANIZATION;

ANIMALS; CELL PROLIFERATION; COST-BENEFIT ANALYSIS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; LYMPHOMA, FOLLICULAR; WORLD HEALTH ORGANIZATION;

EID: 74249102640     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/PAI.0b013e3181bc84f4     Document Type: Review

References (39)

1. Taylor CR. The WHO classification of lymphomas: cost effective Immunohistochemistry using a deductive reasoning "Decision Tree" approach. Review Part I. Appl Immunohistochem Mol Morph. 2009. In press.
2. Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumors of the haematopoietic and lymphoid tissues. IARC. Geneva: WHO Press; 2008.
3. Lee Y, Terry R, Lukes RJ. Lymph node biopsy for diagnosis: a statistical study. J Surg Oncol. 1980;14:53-60.
4. Robb-Smith AHT, Taylor CR. Lymph Node Biopsy. Oxford: Oxford University Press; 1980.
5. Isaacson PG. Haematopathology practice: the commonest problems encountered in consultation practice. Histopathology. 2007;50: 821-834.
6. Wright DH, Addis BJ, Leong AS-Y. Diagnostic Lymph Node Pathology. London: Hodder Arnold; 2006.
7. Weiss L. Lymph Nodes. Cambridge: Cambridge Medicine; 2008.
8. Siqueira SAC, Alves VAF, Beitler B, et al. Contribution of immunohistochemistry to small B-cell lymphoma classification. Appl Immunohistochem Mol Morph. 2006;14:1-6.
9. Leong AS, Yin H, Hafajee Z. Patterns of immunoglobulin staining in paraffin embedded malignant lymphomas. Appl Immunohistochem Mol Morph. 2002;10;110-114.
10. Marshall-Taylor CE, Cartun RW, Mandich D, et al. Immunohistochemical detection of immunoglobulin light chain expression in B-cell non-Hodgkin lymphomas using formalin-fixed, paraffinembedded tissues and a heat-induced epitope retrieval technique. Appl Immunohistochem Mol Morph. 2002;10:258-262.
11. Adams H, Liebisch P, Schmid P, et al. Diagnostic utility of the B cell markers CD20, CD79a, PAX5, and CD19 in paraffin-embedded tissues from lymphoid neoplasms. Appl ImmunohistochemMolMorph. 2009;17:96-101.
12. Loddenkemper C, Anagnostopoulos I, HummelM, et al. differential emu enhancer activity and expression of BOB.1/OBF.1, Oct2, PU.1, and immunoglobulin in reactive B-cell populations, B-cell non- Hodgkin lymphomas, and Hodgkin lymphomas. J Pathol. 2004; 202:60-69.
13. Wang J, Young L, Win W, et al. Distribution and ZAP-70 expression of WHO lymphoma categories in Shanxi, China: a review of 447 cases using a tissue microarray technique. Appl Immunohistochem Mol Morph. 2005;13:323-332.
14. Tzankov A, Meier C, Hirschmann P, et al. Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma. Haematologica. 2008;93:193-200.
15. Xu Y, McKenna RW, Doolittle JE, et al. The t(14;18) in diffuse large B-cell lymphoma: correlation with germinal center-associated markers and clinical features. Appl Immunohistochem Mol Morph. 2005;13:116-123.
16. Pruneri G, Valentini S, Bertolini F, et al. SP4, a novel anticyclin D1 rabbit monoclonal antibody, is a highly sensitive probe for identifying mantle cell lymphomas bearing the t(11;14) (q13;q32) translocation. Appl Immunohistochem Mol Morph. 2005;13: 318-322.
17. Cummins R, Lonergan F, O'Grady A, et al. A simple antigen retrieval method for the optimal demonstration of cyclin-D1 overexpression in formalin-fixed paraffin-embedded cases of mantle cell lymphoma. Appl Immunohistochem Mol Morph. 2005;13:287-291.
18. Gatter KC, Alcock C, Heryat A, et al. Clinical importance of analyzing malignant tumours of uncertain origin with immunohistochemical techniques. Lancet. 1985;1:1302-1305.
19. Klapper W, Szczepanowski M, Burkhardt B, et al. Molecular profiling of pediatric mature B-cell lymphoma treated in population-based prospective clinical trials. Blood. 2008;112: 1374-1381.
20. Hsi E, Said J. Lymphoma including hodgkin lymphoma. In: Taylor CR, Cote RC. Immunomicroscopy. A Diagnostic Tool for the Surgical Pathologist. 3rd ed. Philadelphia: Saunders Elsevier; 2006: 103-153. Chapter 4.
21. Bonzheim I, Geissinger E, Tinguely M, et al. Evaluation of FoxP3 expression in peripheral T-cell lymphoma. Am J Clin Pathol. 2008; 130:613-619.
22. Bahrami A, Truong LD, Ro JY. Undifferentiated tumor. True identity by immunohistochemistry. Arch Pathol Lab Med. 2008;132: 326-346.
23. Taylor CR, Cote RC. Immunomicroscopy. A Diagnostic Tool for the Surgical Pathologist. 3rd ed. Philadelphia: Saunders Elsevier; 2006.
24. Sjo LD, Poulsen CB, Hansen M, et al. Profiling of diffuse large B-cell lymphoma by immunohistochemistry: identification of prognostic subgroups. Eur J Haematol. 2007;79:501-507.
25. de Jong D, Rosenwald A, Chhanabhai M, et al. Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications-a study from the Lunenburg Lymphoma Biomarker Consortium. J Clin Oncol. 2007;25:805-812.
26. Bai M, Skyrlas A, Agnantis NJ, et al. Diffuse large B-cell lymphomas with germinal center B-cell-like differentiation immunophenotypic profile are associated with high apoptotic index, high expression of the proapoptotic proteins bax, bak and bid and low expression of the antiapoptotic protein bcl-xl. Modern Pathol. 2004;17:847-856.
27. Dybkaer K, Iqbal J, Zhou G, et al. Molecular diagnosis and outcome prediction in diffuse large B-cell lymphoma and other subtypes of lymphoma. Clin Lymphoma. 2004;5:19-28.
28. Chabay MM, De Matteo E, Preciado MV. Immunohistochemical expression of p53, bcl-2, and p21 in 48 Argentinian children with non-Hodgkin lymphoma. Appl Immunohistochem Mol Morph. 2006;14:12-17.
29. Natkunam Y, Soslow R, Matolcsy A, et al. Immunophenotypic and genotypic characterization of progression in follicular lymphomas. Appl Immunohistochem Mol Morph. 2004;12:97-104.
30. Taylor CR. Hodgkin's disease is a non-Hodgkin lymphoma. Hum Pathol. 2005;36:1-4.
31. Taylor CR, Riley CR. Molecular morphology of Hodgkin lymphoma. Appl Immunohisochem Mol Morph. 2001;9:187-202.
32. Stein H, Marafioti T, Foss HD et al. Down-regulation of BOB. 1/OBF.1 and Oct2 in classical Hodgkin disease but not in lymphocyte predominant Hodgkin disease correlates with immunoglobulin transcription. Blood. 2001;97:496-501.
33. Magro CM, Nash JW, Werling RW, et al. Primary cutaneous CD30+ large cell B-cell lymphoma: a series of 10 cases. Appl Immunohistochem Mol Morph. 2006;14:7-11.
34. Marsee DK, Pinkus GS, Hornick JL. Podoplanin (D2-40) is a highly effective marker of follicular dendritic cells. Appl Immunohistochem Mol Morph. 2009;17:102-107.
35. Yaziji H, Taylor CR. Begin at the beginning, with the tissue! The key message underlying the ASCO/CAP task-force guideline recommendations for HER2 testing. Appl Immunohistochem Mol Morph. 2007;15:239-241.
36. Goldstein NS, Hewitt SM, Taylor CR, et al. Committee on immunohiostochemistry standardization. Recommendations for improved standardization of immunohistochemistry. Appl Immunohistochem Mol Morph. 2007;15:124-133.
37. Taylor CR, Levenson RM. Quantification of immunohistochemistry- issues concerning methods, utility and semiquantitative assessment. Histopathology. 2006;49:411-424.
38. Taylor CR. Quantifiable internal reference standards for immunohistochemistry; the measurement of quantity by weight. Appl Immunohistochem Mol Morph. 2006;14:253-259.
39. Seliem RM, Freeman JK, Steingart RH, et al. Immunophenotypic changes and clinical outcome in B-cell lymphomas treated with rituximab. Appl Immunohistochem Mol Morph. 2006;14: 18-23.